Novartis invests $55m in US gene therapy site, prepares BLA – BioPharma-Reporter.com
BioPharma-Reporter.com |
Novartis invests $55m in US gene therapy site, prepares BLA
BioPharma-Reporter.com The clinical-stage gene therapy firm will invest $55m into the site – located in Research Triangle Park, North Carolina, US – and add 200 jobs in engineering, manufacturing and quality control, and supply chain roles. “As a long-established … |
